Entry |
|
Name |
IGF2-overexpression to RAS-ERK signaling pathway
|
Definition |
IGF2* -> IGF1R -> GRB2 -> SOS -> RAS -> RAF -> MEK -> ERK |
Expanded |
3481v1 -> 3480 -> 2885 -> (6654,6655) -> (3265,3845,4893) -> (369,673,5894) -> (5604,5605) -> (5594,5595) |
Class |
|
Type |
Variant
|
Pathway |
|
Disease |
H00048 | Hepatocellular carcinoma |
|
Gene |
3481 | IGF2; insulin like growth factor 2 |
3480 | IGF1R; insulin like growth factor 1 receptor |
2885 | GRB2; growth factor receptor bound protein 2 |
6654 | SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 |
6655 | SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 |
3265 | HRAS; HRas proto-oncogene, GTPase |
3845 | KRAS; KRAS proto-oncogene, GTPase |
4893 | NRAS; NRAS proto-oncogene, GTPase |
369 | ARAF; A-Raf proto-oncogene, serine/threonine kinase |
673 | BRAF; B-Raf proto-oncogene, serine/threonine kinase |
5894 | RAF1; Raf-1 proto-oncogene, serine/threonine kinase |
5604 | MAP2K1; mitogen-activated protein kinase kinase 1 |
5605 | MAP2K2; mitogen-activated protein kinase kinase 2 |
5594 | MAPK1; mitogen-activated protein kinase 1 |
5595 | MAPK3; mitogen-activated protein kinase 3 |
|
Variant |
3481v1 (IGF2*) IGF2 overexpression
|
Reference |
|
Authors |
Whittaker S, Marais R, Zhu AX |
Title |
The role of signaling pathways in the development and treatment of hepatocellular carcinoma. |
Journal |
|
Reference |
|
Authors |
Breuhahn K, Longerich T, Schirmacher P |
Title |
Dysregulation of growth factor signaling in human hepatocellular carcinoma. |
Journal |
|
Reference |
|
Authors |
Villanueva A, Newell P, Chiang DY, Friedman SL, Llovet JM. |
Title |
Genomics and signaling pathways in hepatocellular carcinoma. |
Journal |
|
Reference |
|
Authors |
Kudo M |
Title |
Signaling pathway and molecular-targeted therapy for hepatocellular carcinoma. |
Journal |
|